NOTA:FRA
Novartis AG
€145,00
arrow_upward
+1,40%(+2,00) 1D
10 Nov., 15:43:26 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOTA...
Open
€145,00
High
€145,00
Low
€145,00
Mkt. cap
331,27 mjd
Avg. vol.
8,00
Volume
0,00
52-wk high
€146,00
52-wk low
€105,50
No. of employees
75 k
Open
€145,00
High
€145,00
Low
€145,00
Mkt. cap
331,27 mjd
Avg. vol.
8,00
Volume
0,00
52-wk high
€146,00
52-wk low
€105,50
No. of employees
75 k
News stories
From web sources and news partners
Yahoo Finance Singapore
·
39 minute gelede
Former Novartis CEO on What AI Can’t Replace in the Workplace
Yahoo Finance UK
·
4 uur gelede
Novartis ranks first place in 2026 Access to Medicine Index
The Business Journals
·
22 uur gelede
Durham-made gene therapy under FDA investigation over tumor reports
Investing.com
·
3 dae gelede
Novartis shelves potential blockbuster pelacarsen as landmark study fails
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 k
Founded07 Mrt. 1996
HeadquartersBasel, Basel City, Switserland
SectorHealth Care
IndustryPharmaceutical industry
Websitenovartis.com